Foraviset Welcomes Prof. Tasuku Harada to Advisory Board – Foraviset
Foraviset shared a post on LinkedIn:
“We are pleased and honored to announce yet another outstanding addition to Foraviset’s expanding Scientific Advisory Board: Prof. Tasuku Harada, President of Tottori University, Japan.
It’s hard to capture Prof. Harada’s career in a single post – but a few highlights speak for themselves:
- President, Tottori University (2025– )
- Vice President, Tottori University (2023-2025)
- Director, Tottori University Hospital (2017-2023)
- Professor, Obstetrics and Gynecology, Tottori University Faculty of Medicine (2008-2023)
Prof. Harada is also the former President of the Japan Society of Endometriosis and the Asian Society of Endometriosis and Adenomyosis (ASEA), and has held board roles with the World Endometriosis Society (WES) and the Society of Endometriosis and Uterine Disorders (SEUD).
Prof. Harada graduated from Tottori University in 1983, and trained in IVF-ET at the University of Leeds (UK) in 1985.
He has (co)authored 220+ peer-reviewed publications. He also served as chief investigator in the drug development of eight therapies for endometriosis and dysmenorrhea in Japan, and edited the Springer book ‘Endometriosis Pathogenesis and Treatment’ (2014).
As a member of Foraviset’s Scientific Advisory Board, Prof. Harada will contribute strategic scientific and clinical guidance, support trial readiness, and help strengthen the academic rigor behind our non-hormonal approach to endometriosis and broader uterine health.
We are proud to welcome Prof. Harada at this pivotal stage of our journey.”
Uri Dior, Co-Chief Medical Officer at Foraviset, shared a post, adding:
“Very excited to be joined, on our Scientific Advisory Board, by the esteemed Prof. Tasuku Harada, an inspiring leader in the research and treatment of endometriosis. Welcome.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 13, 2026, 18:55Khalil Faaed: The Next Revolution in IVF May Not Be AI or PGT-A It May Be Piezo-ICSI
-
Jun 13, 2026, 18:49Some Exciting Research, Reviews, Perspectives, and Editorial in Our June Issue – The Lancet Obstetrics, Gynaecology, and Women’s Health
-
Jun 13, 2026, 18:38Amos Grünebaum: Alcohol Guidance in Pregnancy Needs Public Health Clarity
-
Jun 13, 2026, 18:31Julius Kwabena Karikari: Excited to Share Our Publication in IJGO on the Determinants of Obstructed Labor
-
Jun 13, 2026, 18:16Sergio Haimovich: New episode of Hystero360 by Global Community of Hysteroscopy
-
Jun 13, 2026, 18:11Evaluating the Oncologic Impact of Statin Use in Gynecologic Cancers – IJGC
-
Jun 13, 2026, 18:03Elvira Brătilă: Progress in Endometriosis Care Is Driven by Science and Collaboration
-
Jun 13, 2026, 15:58Sergei Gorlovetsky: Excited to Be Attending ESHRE 2026 in London as Part of Fertiligent AI
-
Jun 13, 2026, 15:50The Real Reason IVF Success Falls With Age – Fertility Plus